Photo taken from Talha Badar/X
Jan 1, 2024, 04:39
Talha Badar: Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL here
Talha Badar, Hematologist/Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:
“Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL here. With median fu of 53 mo DFS and OS are 75.8% and 80.7%! IKZF1 plus and emergence of T315I suggestive of inferior outcome.”
Source: Talha Badar/X
Jul 26, 2024, 08:02